Patent · US Expired

compounds of heteroaryl substituted imidazole, their pharmaceutical compositons and uses

US6335340B1 · kind B1 · utility

24Cited by
6References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 16, 2000
Grant dateJan 1, 2002
Priority date
Expiry dateJun 16, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of 1,4,5-substituted imidazole wherein one of the substituents can be a substituted pyrimidine, pyridazine or 1,2,4-triazine. These compounds and their pharmaceutical compositions are used in treating cytokine mediated diseases by inhibiting the production of IL-1 (interleukin-1), IL-8 (interleukin-8), and TNF (tumor necrosis factor).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.